| dc.contributor.author | Harrison, Paul J | |
| dc.date.accessioned | 2022-07-14T14:34:32Z | |
| dc.date.available | 2022-07-14T14:34:32Z | |
| dc.date.issued | 2022-04 | |
| dc.identifier.citation | Tony Kirby. Paul Harrison—investigating the psychiatric sequelae of COVID-19. Lancet Psychiatry INSIGHT PROFILE VOLUME 9, ISSUE 5, P350, MAY 01, 2022 | en |
| dc.identifier.uri | https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/1098 | |
| dc.description.abstract | Paul Harrison describes his academic career as being low profile until several large studies on the psychiatric effects of COVID-19, including those linked to so called long-COVID, thrust him and his team into the limelight. “These studies and others leave little doubt that mental and brain health can be damaged by COVID-19, and these effects can be long-lasting”, Harrison tells The Lancet Psychiatry. Today, he is about to celebrate 25 years as professor of psychiatry at the University of Oxford, UK. He is Associate Head of Department (Research), chair of the Oxford Neuroscience Committee, and also works as an honorary consultant in general adult psychiatry at Oxford Health NHS Foundation Trust. | en |
| dc.description.uri | https://doi.org/10.1016/S2215-0366(22)00116-X | en |
| dc.language.iso | en | en |
| dc.subject | COVID-19 | en |
| dc.subject | Mental Disorders | en |
| dc.title | Paul Harrison—investigating the psychiatric sequelae of COVID-19 | en |
| dc.type | Article | en |